Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Fashion among 5 stocks flashing bullish signals, hinting at a possible uptrend
Five Nifty500 stocks that gained over 5% appeared on the White Marubozu bullish scanner on May 21, signalling strong buying momentum. The candlestick pattern reflects sustained bullish pressure throughout the session, indicating buyers dominated price action and suggesting a potential continuation of the uptrend in the near term.
Aditya Birla Group bets big on IPL boom, says media rights frenzy is far from over
Aditya Birla Group sees strong future growth for Indian sports. The group believes IPL media rights will keep increasing in value. This is despite current worries about fewer bidders. India's economy and sports viewership are rising. Premium sports assets are also scarce. This supports future valuations. The group recently bought Royal Challengers Bengaluru. They are optimistic about the long-term trend.
LIC profit rises 23% in March quarter on all-round show
Life Insurance Corp announced a strong March quarter profit, up 23% to ₹23,467 crore. This growth was fueled by increased premiums and investment income. For the full year, profit after tax rose 19%. The company anticipates geopolitical tensions may affect savings flows. LIC is focusing on protection products and expects continued double-digit growth in new business premiums.
LIC Q4 Results: Profit rises 23% YoY to Rs 23,467 crore; co declares Rs 10 per share dividend
LIC Q4 Results: State-owned Life Insurance Corp (LIC) reported a 23% year-on-year (YoY) growth in its consolidated net profit at Rs 23,467 crore in the fourth quarter of FY26, compared with Rs 19,039 crore in the last-year period.
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?
Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady margin outlook despite higher R&D spending, with EBITDA growth supported by diversified global business momentum outlook

Century Enka Q4 Results: Aditya Birla Group stock up 20% on multi-fold profit growth
Century Enka shares surged 20% after the Aditya Birla Group firm reported a sharp jump in fourth-quarter profit and margins, driven by a strong improvement in operating performance.

Buy, Sell Or Hold: Hitachi Energy, JK Tyre, Aditya Birla Capital, PNB, Maruti Suzuki, GAIL — Ask Profit
Buy Sell Hold

Can silver ETFs face supply issues after India’s import restrictions? What should investors do
India's bullion market faces challenges as import duties on gold and silver rise to 15%. The move aims to curb imports and stabilize the rupee amidst global uncertainties. Concerns emerge over silver ETF supply due to new import restrictions, potentially leading to higher domestic premiums.
LIC to announce Q4 results today: Here's what to expect from the insurance behemoth
Life Insurance Corp (LIC) is poised to reveal its March quarter earnings today. Investors are keenly awaiting insights into new business growth, profit margins, and market share trends amidst escalating competition. Brokerages anticipate robust premium growth, driven by a favorable product mix and a strategic shift towards non-participating policies, signaling a positive outlook for the insurance giant.
Gold loans rise 50% to Rs 19 lakh crore in FY26
Gold jewellery loans have seen a massive 50 percent jump year-on-year, reaching ₹19 lakh crore. This makes it the fastest growing retail loan category. The surge is driven by rising gold prices and a shift in borrowing habits. This growth has boosted the overall retail loan market. Asset quality has also improved with declining delinquency levels across most segments.

Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Aditya Birla Grp to invest Rs 3,080 cr in fin services arm, IFC to pump Rs 920 cr
Aditya Birla Capital is raising Rs 4,000 crore for future growth. The Aditya Birla Group will invest Rs 3,080 crore and IFC will invest Rs 980 crore. This capital infusion will fund growth objectives, including lending and investments. The company aims to expand access to financing for entrepreneurs and businesses. This move supports India's economic transformation and financial inclusion.